Basic Information of the Drug
-
Drug Name: Compound Polyethylene Glycol (3350) Electrolyte Oral Solution
-
Main Ingredients: Polyethylene Glycol 3350; Sodium Chloride; Sodium Bicarbonate; Potassium Chloride
-
Application Type: Drug Registration Application
-
Specification: 25ml/bag
-
Registration Category: Chemical Drug
-
Drug Approval Number: National Drug Standard H20263376
-
Approval Date: [blank]
-
Approval Basis: According to the relevant regulations of the "Drug Registration Management Measures" and related guidelines, the registration of this drug is required. The quality standards and specifications are implemented in accordance with the relevant regulations.
-
It is recommended that the company strengthen the control of raw materials and further refine the production process.
-
The product is allowed for sale to individuals and enterprises, and the company will actively promote the product in the market.
Risk Reminder
The Compound Polyethylene Glycol (3350) Electrolyte Oral Solution has obtained the drug registration certificate, and the company will actively promote it. The company will continue to pay attention to market dynamics and regulatory policies, ensuring that sales performance is not guaranteed. Investors are advised to be cautious of investment risks.
Supplementary Documents
- Compound Polyethylene Glycol (3350) Electrolyte Oral Solution Drug Registration Certificate.
This announcement is issued by Sunflower Pharmaceutical Group Co., Ltd.
Chairman